Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LAZERTINIB vs LECANEMAB-IRMB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LAZERTINIB vs LECANEMAB-IRMB: Safety Overview

Metric LAZERTINIB LECANEMAB-IRMB
Total FAERS Reports 352 2,469
Deaths Reported 15 82
Death Rate 4.3% 3.3%
Hospitalizations 83 474
Average Patient Age 66.6 yrs 74.1 yrs
% Female Patients 59.9% 58.6%
FDA Approval Date Aug 19, 2024 N/A
Manufacturer Janssen Biotech, Inc. Eisai Inc.
Route ORAL N/A
Marketing Status Prescription Prescription